Fundraising Fox

Insmed

NASDAQ: INSM

<UNKNOWN>, US · Incorporated in Virginia · 5 known investors

Insmed is a biopharmaceutical company that provides grants and charitable funding to support healthcare provider education and patient care initiatives focused on nontuberculous mycobacterial lung disease, non-cystic fibrosis bronchiectasis, and other serious lung diseases.

BiotechDigital HealthHealthtechMedical Devicesin /insmed @Insmed

Investors · 5

Bessemer Venture PartnersRedwood City · $5M – $100M

F-Prime Capital PartnersCambridge · $3M – $10M

Foresite CapitalLarkspur

OrbiMedNew York · $1M – $75M

Prospect Venture PartnersMenlo Park · $3M – $5M

Acquisitions · 1

Early investors' stakes continue via these deals

Adrestia Therapeutics

Early-stage drug discovery platform, acquired by Insmed

In the news

Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · 2026
Seeds | Jumps to World Model Unicorn in One Year! Manifold AI Raises Hundreds of Millions in New Funding | Gasgooautonews.gasgoo.com · 2026
Fei-Fei Li's World Labs Raises $1B in Fresh Funding to Advance Development of World Modelstheaiinsider.tech · 2026